INVO Bioscience, Inc.'s ticker is INVO and the CUSIP is 44984F104. A total of 2 filers reported holding INVO Bioscience, Inc. in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $26,000 | -7.1% | 59,970 | 0.0% | 0.01% | -28.6% |
| Q2 2018 | $28,000 | -12.5% | 59,970 | 0.0% | 0.01% | -12.5% |
| Q1 2018 | $32,000 | +255.6% | 59,970 | 0.0% | 0.01% | +300.0% |
| Q4 2017 | $9,000 | -30.8% | 59,970 | 0.0% | 0.00% | -33.3% |
| Q3 2017 | $13,000 | -27.8% | 59,970 | 0.0% | 0.00% | -40.0% |
| Q2 2017 | $18,000 | -18.2% | 59,970 | 0.0% | 0.01% | -28.6% |
| Q1 2017 | $22,000 | +4.8% | 59,970 | 0.0% | 0.01% | -22.2% |
| Q4 2016 | $21,000 | +5.0% | 59,970 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $20,000 | -16.7% | 59,970 | 0.0% | 0.01% | -10.0% |
| Q2 2016 | $24,000 | +9.1% | 59,970 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $22,000 | -42.1% | 59,970 | +9.1% | 0.01% | -47.4% |
| Q4 2015 | $38,000 | +52.0% | 54,970 | +2.6% | 0.02% | +35.7% |
| Q3 2015 | $25,000 | +13.6% | 53,570 | 0.0% | 0.01% | +16.7% |
| Q2 2015 | $22,000 | +57.1% | 53,570 | 0.0% | 0.01% | +200.0% |
| Q1 2015 | $14,000 | – | 53,570 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corrigan Financial, Inc. | 14,705 | $6,470 | 0.01% |
| Vantage Investment Advisors, LLC | 59,970 | $26,000 | 0.01% |